Home Special Topics Technology Offerings Content

Gold Nanoparticles Functionalized with Dendritic Polyglycerol Sulfates

next article

25.01.2013

<strong>Background</strong><br> As selectins mediate the first contacts of leukocytes to the endothelium, the initial events of all kind of inflammatory responses, selectins are ideal targets for the therapeutic intervention of inflammatory diseases. <br><br> Dendritic polyglycerol sulfates (dPGS) alone and with aminoalcohols functionalized gold nanoparticles each have been shown to be good selectin inhibitors, as they prevent L- and P-selectins to bind their natural ligands with IC50 values in the nanomolar and picomolar range. <br><br> <strong>Technology</strong><br> We offer synthesized gold nanoparticles functionalized with highly branched polyglycerol sulfates, showing a high affinity for L- and P-selectins with IC50 values in the femtomolar range and therefore having a better anti-inflammatory potential compared to dPGS and aminoalcohol-functionalized nanoparticles alone. <br><br> Besides their use in the therapy of inflammatory diseases, dPGS-functionalized nanoparticles can also be used for diagnostic purposes. By using dPGS functionalized nanoparticles, selectin expressing inflammatory tissues can be localized and visualized. <br><br> <strong>Benefits</strong> <ul> <li>Improved selectin inhibition with IC50 = 180 fM </li> <li>Branched polyglycerols show high biocompatibility</li> <li>Visualization of gold nanoparticles by MRT possible </li> </ul> <p><strong>IP Rights</strong><br> DE patent application filed 05/2011<br> PCT application filed 05/2012 <br><br> <strong>Patent Owner</strong><br> Charité Universitätsmedizin Berlin<br> Freie Universität Berlin</p>

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

info@technologieallianz.de | Source: TechnologieAllianz e.V.
Further information: www.technologieallianz.de/angebote.php?sort=sag&id=3024&lang=en
www.technologieallianz.de

next article